[18F]Fluciclatide PET as a Biomarker of Response to Combination Therapy of Pazopanib and Paclitaxel in Platinum-Resistant/Refractory Ovarian Cancer

European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-019-04532-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Oral Melphalan as a Treatment for Platinum-Resistant Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2003English

Pcn333 - Real-World Treatment Patterns of Patients With Advanced (Stage Ii-Iv) Ovarian Cancer Classified as Resistant or Refractory to Frontline Platinum-Based Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn384 - Health-Related Quality of Life in Patients With Advanced (Stage Ii-Iv) Ovarian Cancer Resistant or Refractory to Frontline Platinum-Based Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Multicenter Reproducibility of 18f-Fluciclatide PET Imaging in Subjects With Solid Tumors

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Emodin Sensitizes Paclitaxel-Resistant Human Ovarian Cancer Cells to Paclitaxel-Induced Apoptosis in Vitro

Oncology Reports
MedicineCancer ResearchOncology
2009English

Emerging Role for Bevacizumab in Combination With Chemotherapy for Patients With Platinum-Resistant Ovarian Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

A Phase I/Ii Study of GLIF Combination Chemotherapy for Taxane/Platinum-Refractory/Resistant Endometrial Cancer (GOGO-EM2)

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Pharmacokinetics of Paclitaxel and Metabolites in a Randomized Comparative Study in Platinum-Pretreated Ovarian Cancer Patients.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy